Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Bulletin Du Cancer
|
October 9, 2002
[Cancer of the breast and pregnancy: the point of view of the breast cancer specialist]
Laurent Mignot
La Revue Du Praticien
|
May 26, 2009
[Tumours of testis]
Christophe Le Tourneau, Laurent Mignot
La Revue Du Praticien
|
April 6, 2006
[Testicular tumors]
Christophe Le Tourneau, Laurent Mignot
Bulletin Du Cancer
|
February 18, 2006
[Oxaliplatin and ovarian cancer]
Véronique Dieras, Véronique Girre, Marie-Noëlle Guilhaume, et al.
Bulletin Du Cancer
|
March 21, 2007
[Trastuzumab (Herceptin) and breast cancer: mechanisms of resistance]
Véronique Dieras, Anne Vincent-Salomon, Armelle Degeorges, et al.
European Urology
|
October 4, 2002
After cystectomy, is it justified to perform a bladder replacement for patients with lymph node positive bladder cancer?
Thierry Lebret, Jean-Marie Herve, Laurent Yonneau, et al.
Clinical & Experimental Metastasis
|
November 8, 2008
Time to metastatic relapse and breast cancer cells dissemination in bone marrow at metastatic relapse
François-Clément Bidard, Anne Vincent-Salomon, Brigitte Sigal-Zafrani, et al.
Bulletin Du Cancer
|
May 6, 2011
[Survival of breast cancers patients with meningeal carcinoma]
Hélène Petithuguenin Gauthier, Marie-Noëlle Guilhaume, François-Clément Bidard, et al.
European Urology
|
September 20, 2011
Gemcitabine or gemcitabine plus oxaliplatin in the first-line treatment of patients with advanced transitional cell carcinoma of the urothelium unfit for cisplatin-based chemotherapy: a randomized phase 2 study of the French Genitourinary Tumor Group (GETUG V01)
Stéphane Culine, Aude Fléchon, Aline Guillot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2008
Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse
Francois-Clément Bidard, Anne Vincent-Salomon, Stéphanie Gomme, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Bulletin Du Cancer
|
October 9, 2002
[Cancer of the breast and pregnancy: the point of view of the breast cancer specialist]
Laurent Mignot
La Revue Du Praticien
|
May 26, 2009
[Tumours of testis]
Christophe Le Tourneau, Laurent Mignot
La Revue Du Praticien
|
April 6, 2006
[Testicular tumors]
Christophe Le Tourneau, Laurent Mignot
Bulletin Du Cancer
|
February 18, 2006
[Oxaliplatin and ovarian cancer]
Véronique Dieras, Véronique Girre, Marie-Noëlle Guilhaume, et al.
Bulletin Du Cancer
|
March 21, 2007
[Trastuzumab (Herceptin) and breast cancer: mechanisms of resistance]
Véronique Dieras, Anne Vincent-Salomon, Armelle Degeorges, et al.
European Urology
|
October 4, 2002
After cystectomy, is it justified to perform a bladder replacement for patients with lymph node positive bladder cancer?
Thierry Lebret, Jean-Marie Herve, Laurent Yonneau, et al.
Clinical & Experimental Metastasis
|
November 8, 2008
Time to metastatic relapse and breast cancer cells dissemination in bone marrow at metastatic relapse
François-Clément Bidard, Anne Vincent-Salomon, Brigitte Sigal-Zafrani, et al.
Bulletin Du Cancer
|
May 6, 2011
[Survival of breast cancers patients with meningeal carcinoma]
Hélène Petithuguenin Gauthier, Marie-Noëlle Guilhaume, François-Clément Bidard, et al.
European Urology
|
September 20, 2011
Gemcitabine or gemcitabine plus oxaliplatin in the first-line treatment of patients with advanced transitional cell carcinoma of the urothelium unfit for cisplatin-based chemotherapy: a randomized phase 2 study of the French Genitourinary Tumor Group (GETUG V01)
Stéphane Culine, Aude Fléchon, Aline Guillot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2008
Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse
Francois-Clément Bidard, Anne Vincent-Salomon, Stéphanie Gomme, et al.
Page
of 2